ImCheck Therapeutics Appoints Dr. Loui Madakamutil as CSO

NEXT STORY
Affimed Reports 2020 Financial Results and Highlights Recent Operational Progress
PREV STORY
While ElsaLys continues to work on the filing of marketing approval in Europe and the U.S. for inolimomab, the company confirms the renew of its cohort ATU in France and compassionate use programs submissions in several other countries
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aerami Therapeutics Announces Orphan Drug Designation for Imatinib for the Treatment of Pulmonary Arterial Hypertension

author_avatar
NASDAQ Market News

Gait Rehabilitation System Market Size to Outstrip $451.11Mn by 2028 Growth Projections at 5.8% CAGR During 2021 to 2028 COVID Impact and Global Analysis by TheInsightPartners.com

author_avatar
NASDAQ Market News

Cend Therapeutics Announces First Patient Dosing in Clinical Trial of CEND-1 for the Treatment of Selected Gastrointestinal Cancers

author_avatar
NASDAQ Market News